Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.54 and traded as low as $0.75. Eagle Pharmaceuticals shares last traded at $0.75, with a volume of 1,281 shares changing hands.
Eagle Pharmaceuticals Trading Up 2.7%
The company has a market capitalization of $9.74 million, a P/E ratio of 0.64 and a beta of 0.83. The stock has a 50 day moving average price of $2.32 and a 200 day moving average price of $2.54.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc, a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma.
Read More
- Five stocks we like better than Eagle Pharmaceuticals
- Energy and Oil Stocks Explained
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- Investing in the High PE Growth Stocks
- Why Vertical Aerospace Stock Could Double After This Flight Test
- What to Know About Investing in Penny Stocks
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
